Novo Nordisk and Hims & Hers Turn Patent Dispute Into Business Opportunity
- Posted on March 10, 2026
- By International Business Times
- 6 Views
Novo Nordisk and Hims & Hers Turn Patent Dispute Into Business Opportunity
Novo Nordisk drops its lawsuit against Hims & Hers as the companies partner to offer FDA-approved Wegovy and Ozempic through the telehealth platform.
